| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.8M | +97.9% | +37.6% |
| Cost of Revenue | $22.3M | +92.9% | +52.7% |
| Gross Profit | $8.5M | +112.5% | +9.3% |
| R&D Expense | $48.8M | +6.5% | +63.3% |
| SG&A Expense | $21.9M | +74.4% | +112.7% |
| Operating Income | -$62.2M | -14.4% | -81.9% |
| Interest Expense | $2.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $995.2M | +384.8% | +3675.4% |
| Accounts Receivable | $5.1M | -9.1% | — |
| Current Assets | $1.02B | +336.9% | — |
| Total Assets | $1.26B | +169.1% | — |
| Current Liabilities | $164.9M | +11.9% | — |
| Long-term Debt | $113.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$137.7M | — | — |
| Capital Expenditures | $20.8M | — | — |
| Investing Cash Flow | -$20.8M | — | — |
| Financing Cash Flow | $1.02B | — | — |
| Free Cash Flow | -$158.4M | — | — |
| -59.4% |
| -56.7% |
| Pre-tax Income | -$133.4M | -109.2% | -227.1% |
| Income Tax | $0 | — | — |
| Net Income | -$133.4M | -109.2% | -227.1% |
| EPS (Basic) | -$1.50 | +74.0% | +58.0% |
| EPS (Diluted) | -$1.50 | +74.0% | +58.0% |
| -17.0% |
| — |
| Total Liabilities | $307.4M | -25.3% | — |
| Stockholders' Equity | $948.8M | +203.4% | +242.6% |